| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3700 |
| Trial ID | NCT06189157 |
| Disease | Systemic Lupus Erythematosus |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MB-CART19.1 |
| Phase | Phase1|Phase2 |
| Recruitment status | Not Recruiting |
| Title | An Open-label Phase I/IIa, Multicentre, Interventional Single-arm Trial of MB-CART19.1 in Patients With Refractory SLE |
| Year | 2024 |
| Country | Germany |
| Company sponsor | Miltenyi Biomedicine GmbH |
| Other ID(s) | M-2022-398 |
| Cohort 1 | |||||||||||
|
|||||||||||